1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with thrombin receptor peptide sfllrnp in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (thrombin receptor peptide sfllrnp) | Trials (thrombin receptor peptide sfllrnp) | Recent Studies (post-2010) (thrombin receptor peptide sfllrnp) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 92 | 10 | 29 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, H; Li, N; Zhang, W | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and thrombin receptor peptide sfllrnp
| Article | Year |
|---|---|
Glycoprotein IIb/IIIa inhibition attenuates platelet-activating factor-induced platelet activation by reducing protein kinase C activity.
Topics: Adenosine Diphosphate; Adolescent; Adult; Antibodies, Monoclonal; Blood Platelets; CD11b Antigen; Dose-Response Relationship, Drug; Female; Flow Cytometry; Humans; Immunoblotting; Leukocytes; Male; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; P-Selectin; Peptide Fragments; Peptides; Phosphorylation; Platelet Activating Factor; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Kinase C; Protein-Tyrosine Kinases; Receptors, Thromboxane A2, Prostaglandin H2; Time Factors | 2003 |